Abstract:Gadolinium [Gd(III)]-based polymeric vehicles are gaining attention as potential magnetic resonance imaging (MRI) probes for cancer imaging and diagnosis. In this study, we designed, prepared, and characterized biodegradable block poly[N-(2-hydroxypropyl) methacrylamide] (polyHPMA) copolymer-Gd( III) conjugates through reversible addition-fragmentation chain transfer (RAFT) polymerization, and examined their potential as efficient and biocompatible MRI probes with features that include tunable tumor targeting specificity. An enzyme-sensitive glycylphenylalanylleucylglycine linker (GFLG) was introduced to the backbone of the copolymers, resulting in the formation of a stimuli-responsive linear HPMA copolymer-based agent (pHPMA-DOTA-Gd). The peptide cRGDyK was linked to the copolymer pHPMA-DOTA-Gd, and the resulting copolymer (pHPMA-DOTA-Gd-cRGD) was investigated as a potentially active tumor-targeting MRI contrast agent. The copolymer-Gd(III) conjugates with high molecular weight (MW > 90 kDa) degraded to segments with low MWs (<44 kDa) below the renal threshold. Compared with the clinical agent diethylenediaminepentaacetic acid (DTPA)-Gd, the polymeric conjugates exhibited three-fold more T-1 relaxivity [15.16 mM(-1) s(-1) per gadolinium]. Additionally, gadolinium-based conjugates had greater tumor accumulation in the U87 tumors in mice, and therefore, offered enhanced signal intensity (SI) to MRI. The best in vivo imaging behaviors were mediated by cRGD functionalized conjugates. The 2 polymeric conjugates presented no significant side effects as measured by cytotoxicity, hemocompatibility, and in vivo toxicity studies. Therefore, owing to their great efficacy and good biosafety, the biodegradable block HPMA copolymer-Gd(III) conjugates are promising as targeting MRI probes.

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Gadolinium-based contrast agents for tumor targeting imaging

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Macromolecular MRI Contrast Agents: Structures, Properties and Applications

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Aptamer-Targeted Magnetic Resonance Imaging Contrast Agents and Their Applications

Preparation of linear poly(glycerol) as a T1 contrast agent for tumor-targeted magnetic resonance imaging

Metal-Drug-Protein Assemblies: Gd3+ Self-Enhanced Magnetic Resonance Imaging, High-Sensitive Tumor-Targeting Imaging and Efficient Chemo-Phototherapy

Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis

The Review of Gd(Ⅲ) MRI Contrast Agents with Macromolecule Carrier

Stimuli-responsive Biodegradable and Gadolinium-Based Poly[n-(2-hydroxypropyl) Methacrylamide] Copolymers: Their Potential As Targeting and Safe Magnetic Resonance Imaging Probes

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging.

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity